NO20073850L - Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat - Google Patents
Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfatInfo
- Publication number
- NO20073850L NO20073850L NO20073850A NO20073850A NO20073850L NO 20073850 L NO20073850 L NO 20073850L NO 20073850 A NO20073850 A NO 20073850A NO 20073850 A NO20073850 A NO 20073850A NO 20073850 L NO20073850 L NO 20073850L
- Authority
- NO
- Norway
- Prior art keywords
- terbutaline sulfate
- controlled release
- polymeric composition
- release delivery
- derivative
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 229960005105 terbutaline sulfate Drugs 0.000 title abstract 3
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 229920001285 xanthan gum Polymers 0.000 abstract 2
- 229940082509 xanthan gum Drugs 0.000 abstract 2
- 235000010493 xanthan gum Nutrition 0.000 abstract 2
- 239000000230 xanthan gum Substances 0.000 abstract 2
- 229920001661 Chitosan Polymers 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000004676 glycans Chemical class 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 abstract 1
- 235000017557 sodium bicarbonate Nutrition 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05000985A EP1685831B1 (de) | 2005-01-19 | 2005-01-19 | Pharmazeutische Polymerformulierung zur retardierten Freisetzung von Terbutalinsulfat |
| PCT/EP2005/013530 WO2006076951A1 (en) | 2005-01-19 | 2005-12-29 | Pharmaceutical polymer composition for oral controlled-release delivery of terbutaline sulfate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073850L true NO20073850L (no) | 2007-10-10 |
Family
ID=34933362
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073850A NO20073850L (no) | 2005-01-19 | 2007-07-23 | Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080206334A1 (de) |
| EP (2) | EP1685831B1 (de) |
| KR (1) | KR20070100364A (de) |
| CN (1) | CN101102756A (de) |
| AT (1) | ATE355833T1 (de) |
| BR (1) | BRPI0519622A2 (de) |
| CA (1) | CA2592269A1 (de) |
| DE (1) | DE602005000675T2 (de) |
| EA (1) | EA013969B1 (de) |
| ES (1) | ES2284088T3 (de) |
| NO (1) | NO20073850L (de) |
| WO (1) | WO2006076951A1 (de) |
| ZA (1) | ZA200705660B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110064806A1 (en) * | 2009-09-11 | 2011-03-17 | Transtech Pharma, Inc. | Solid compositions comprising an oxadiazoanthracene compound and methods of making and using the same |
| CN102188399B (zh) * | 2011-04-02 | 2012-12-12 | 南京正科制药有限公司 | 托拉塞米胃漂浮片及其制备方法 |
| CN110057932B (zh) * | 2019-04-22 | 2022-03-15 | 上海旭东海普药业有限公司 | 高效液相色谱分析硫酸特布他林有关物质的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3686275T2 (de) * | 1985-01-11 | 1993-03-18 | Teijin Ltd | Praeparate mit verzoegerter freisetzung. |
| US5620706A (en) * | 1995-04-10 | 1997-04-15 | Universite De Sherbrooke | Polyionic insoluble hydrogels comprising xanthan and chitosan |
-
2005
- 2005-01-19 DE DE602005000675T patent/DE602005000675T2/de not_active Expired - Lifetime
- 2005-01-19 EP EP05000985A patent/EP1685831B1/de not_active Expired - Lifetime
- 2005-01-19 ES ES05000985T patent/ES2284088T3/es not_active Expired - Lifetime
- 2005-01-19 AT AT05000985T patent/ATE355833T1/de not_active IP Right Cessation
- 2005-12-29 BR BRPI0519622-1A patent/BRPI0519622A2/pt not_active IP Right Cessation
- 2005-12-29 EP EP05820497A patent/EP1838299A1/de not_active Withdrawn
- 2005-12-29 CA CA002592269A patent/CA2592269A1/en not_active Abandoned
- 2005-12-29 ZA ZA200705660A patent/ZA200705660B/xx unknown
- 2005-12-29 CN CNA2005800468260A patent/CN101102756A/zh active Pending
- 2005-12-29 WO PCT/EP2005/013530 patent/WO2006076951A1/en not_active Ceased
- 2005-12-29 EA EA200701525A patent/EA013969B1/ru not_active IP Right Cessation
- 2005-12-29 US US11/813,301 patent/US20080206334A1/en not_active Abandoned
- 2005-12-29 KR KR1020077018762A patent/KR20070100364A/ko not_active Ceased
-
2007
- 2007-07-23 NO NO20073850A patent/NO20073850L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101102756A (zh) | 2008-01-09 |
| DE602005000675T2 (de) | 2007-11-15 |
| EA200701525A1 (ru) | 2008-02-28 |
| EP1838299A1 (de) | 2007-10-03 |
| KR20070100364A (ko) | 2007-10-10 |
| DE602005000675D1 (de) | 2007-04-19 |
| US20080206334A1 (en) | 2008-08-28 |
| EP1685831A1 (de) | 2006-08-02 |
| EA013969B1 (ru) | 2010-08-30 |
| WO2006076951A1 (en) | 2006-07-27 |
| ZA200705660B (en) | 2009-01-28 |
| BRPI0519622A2 (pt) | 2009-02-25 |
| ES2284088T3 (es) | 2007-11-01 |
| EP1685831B1 (de) | 2007-03-07 |
| ATE355833T1 (de) | 2007-03-15 |
| CA2592269A1 (en) | 2006-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
| UY32503A (es) | Formulación pesticida de uso agrícola a base de avermectina y un agente fotoprotector | |
| MX2009013832A (es) | Derivados de purina y su uso como moduladores del receptor 7 similar a un puente. | |
| EA200900087A1 (ru) | Применение гидрофильной матрицы, содержащей производное полиакриловой кислоты, простой эфир целлюлозы и дезинтегрирующий агент, в производстве медикаментов для лечения заболеваний женских гениталий | |
| SG196810A1 (en) | Controlled release pharmaceutical or foodformulation and process for its preparation | |
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| TW200716202A (en) | Pediatric formulation of topiramate | |
| ATE493973T1 (de) | Irbesartan enthaltende pharmazeutische zusammensetzung | |
| NO20092662L (no) | Sammensetning med forlenget frigjoring og fremgangsmate for a produsere det samme | |
| CY1107819T1 (el) | Φαρμακευτικη διαμορφωση της ολανζαπινης | |
| NO20062082L (no) | Pellets inneholdende venlafaksinhydroklorid | |
| NO20073850L (no) | Farmasoytisk polymersammensetning for oral kontrollert frigivelsesavlevering av terbutalinsulfat | |
| MX2008010879A (es) | Composiciones farmaceuticas de sodio de fluvastatina. | |
| MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
| EA201070806A1 (ru) | Состав медленного высвобождения на основе ассоциации гликогена и альгината | |
| DE60319983D1 (de) | Universelle Zusammensetzung zur kontrollierten Wirkstoffabgabe enthaltend Chitosan | |
| BRPI0506630A (pt) | composição de liberação controlada e método para administrar um medicamento aquoso transmucosal de liberação controlada | |
| DE60219965D1 (de) | Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine | |
| WO2009008004A3 (en) | Sustained release formulations of divalproex sodium | |
| BRPI0611526A2 (pt) | composição tópica contendo gelatina | |
| UA94275C2 (ru) | Фармацевтическая композиция, которая содержит по крайней мере один активный наркотический или психотропный компонент, назначенный способ введения которых в организм тяжело поддается изменению | |
| JO2440B1 (en) | Formulation of oral pharmaceutical polymers for controlled release of terbutalate sulfate. | |
| JO2571B1 (en) | A general composition of controlled liberation | |
| JO2572B1 (en) | A general formula for controlled release |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |